指南与共识血管炎

2021年美国风湿病学会/血管炎基金会结节性多动脉炎管理指南

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.
指南 / 共识 · Arthritis Care Res (Hoboken) · 2021-07-08

该指南针对系统性非乙肝相关结节性多动脉炎(PAN)制定16条推荐和1条未分级立场声明,涵盖诊断检查、治疗和管理。推荐早期使用环磷酰胺和糖皮质激素治疗重症PAN,并通过减少长期暴露来限制毒性,同时使用影像学和组织活检进行诊断。多数推荐因证据不足被定为条件性推荐。

要点

  • 重症PAN应早期使用环磷酰胺联合糖皮质激素治疗。
  • 通过减少环磷酰胺和糖皮质激素的长期暴露来限制毒性。
  • 使用影像学和组织活检进行PAN的诊断。

核心结论

  • 推荐早期使用环磷酰胺和糖皮质激素治疗重症PAN,并通过减少长期暴露来限制毒性。
  • 推荐使用影像学和组织活检进行疾病诊断。
  • 推荐在疾病起始使用成熟疗法以最小化患者风险,并识别可能需要辅助治疗的新领域。

研究设计与样本

  • 针对系统性非乙肝相关PAN制定21个PICO格式的临床问题,进行系统文献回顾,采用GRADE方法评估证据质量并形成推荐,每条推荐需投票小组≥70%共识。

主要发现

  • 提出16条推荐和1条未分级立场声明,多数推荐因证据缺乏被定为条件性推荐。

关键数值与推荐

  • 每条推荐需投票小组≥70%共识。
  • 推荐早期使用环磷酰胺和糖皮质激素治疗重症PAN。
  • 推荐通过减少环磷酰胺和糖皮质激素的长期暴露来限制毒性。
  • 推荐使用影像学和组织活检进行疾病诊断。

临床怎么用

  • 对重症PAN患者早期使用环磷酰胺联合糖皮质激素,并注意减少长期暴露以降低毒性。
  • 诊断PAN时结合影像学和组织活检。
  • 在疾病起始使用成熟疗法以最小化患者风险。

局限性

  • 多数推荐因证据不足被定为条件性推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). METHODS: Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for systemic, non-hepatitis B-related PAN. Systematic literature reviews were conducted for each PICO question. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of evidence and formulate recommendations. Each recommendation required ≥70% consensus among the Voting Panel. RESULTS: We present 16 recommendations and 1 ungraded position statement for PAN. Most recommendations were graded as conditional due to the paucity of evidence. These recommendations support early treatment of severe PAN with cyclophosphamide and glucocorticoids, limiting toxicity through minimizing long-term exposure to both treatments, and the use of imaging and tissue biopsy for disease diagnosis. These recommendations endorse minimizing risk to the patient by using established therapy at disease onset and identify new areas where adjunctive therapy may be warranted. CONCLUSION: These recommendations provide guidance regarding diagnostic strategies, use of pharmacologic agents, and imaging for patients with PAN.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Chung SA, Gorelik M, Langford CA, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Care Res (Hoboken). 2021. PMID: 34235889. doi:10.1002/acr.24633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。